Mineralys Therapeutics Closes $40 Million Series A Funding
Financing Co-led by HBM Healthcare Investments and Samsara BioCapital
Food and Drug Administration Accepts Investigational New Drug Application for MLS-101 and Advances to Phase 2 Proof-of-Concept Clinical Trial
Company Announces Jon Congleton as Chi... Biopharmaceuticals, Cardiology, Venture Capital, Personnel Mineralys Therapeutics, aldosterone synthase, hypertension
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news